What is chromogenic in situ hybridization used for in medical diagnostics?
Chromogenic in situ hybridization (CISH) is used in medical diagnostics to detect and localize specific DNA or RNA sequences in tissue samples, aiding in the assessment of gene expression patterns, chromosome abnormalities, and identification of pathogens, particularly in cancer diagnostics for detecting gene amplifications or deletions.
How does chromogenic in situ hybridization work?
Chromogenic in situ hybridization (CISH) works by using a labeled DNA or RNA probe to bind to a specific genetic sequence within a tissue sample. An enzyme, linked to the probe, catalyzes a chromogenic reaction, producing a colored precipitate that is visually detected under a microscope, indicating the presence of the target sequence.
What are the advantages of using chromogenic in situ hybridization over other methods?
Chromogenic in situ hybridization offers advantages such as visualizing target DNA or RNA sequences directly in tissue samples with high spatial resolution, utilizing brightfield microscopy, which is commonly available, and providing permanent staining results that can be archived for further evaluation.
What are the limitations of chromogenic in situ hybridization in clinical applications?
Chromogenic in situ hybridization has limitations such as lower sensitivity compared to fluorescence in situ hybridization, challenges in accurately quantifying gene expression, potential for background staining interfering with interpretation, and a limited ability to multiplex, which can hinder the simultaneous analysis of multiple targets on the same tissue section.
What types of samples can be analyzed using chromogenic in situ hybridization?
Chromogenic in situ hybridization (CISH) can be used to analyze a variety of sample types, including formalin-fixed paraffin-embedded (FFPE) tissue samples, fresh frozen tissues, cell blocks, and cytological smears.